|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Available-for-sale securities - taxable | ||||||||||||||||||||
| Available-for-sale securities - tax-exempt | ||||||||||||||||||||
| Loans, net of unearned fees | ||||||||||||||||||||
| Allowance for credit losses on loans | ||||||||||||||||||||
| Loans, net of the allowance for credit losses on loans | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Restricted equity securities | ||||||||||||||||||||
| Interest receivable | ||||||||||||||||||||
| Foreclosed assets held for sale | ||||||||||||||||||||
| Goodwill and other intangible assets, net | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders' equity | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Non-interest-bearing | ||||||||||||||||||||
| Savings, NOW and money market | ||||||||||||||||||||
| Time | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Federal funds purchased and repurchase agreements | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Interest payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||||
| Preferred stock, $0.01 par value: Authorized - 5,000,000 shares; issued - 7,750 shares at September 30, 2024 and December 31, 2023 | ||||||||||||||||||||
| Common stock, $0.01 par value: Authorized - 200,000,000 shares; issued - 53,638,827 and 53,326,641 shares at September 30, 2024 and December 31, 2023, respectively | ||||||||||||||||||||
| Treasury stock, at cost: 3,990,753 and 4,588,398 shares held at September 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Treasury stock, at cost: 4,340,033 and 3,990,753 shares held at September 30, 2024 and December 31, 2023, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
